Research vulnerability: An illustrative case study from the South African mining industry

Developing World Bioethics

Volumn 7, Issue 3, 2007, Pages 119-127

  Horn, Lyn ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Occupational health research; Participatory research; Research ethics; Research vulnerability; Vulnerable research population

Indexed keywords

ARTICLE; BIOETHICS; CASE STUDY; COMMUNITY; CONFIDENTIALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIAL WORKER; INFORMED CONSENT; MEDICAL RESEARCH; MINING; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PANDEMIC; PARTICIPATORY MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVACY; RACISM; RESEARCH ETHICS; SOUTH AFRICA; TAXONOMY; TUBERCULOSIS; VULNERABLE POPULATION;

EID: 36248950979     PISSN: 14718731     EISSN: None     Source Type: Journal    
DOI: 10.1111/dewb_151.x     Document Type: Article

References (42)

1. C. Levine et al. The Limitations of 'Vulnerability' as a Protection for Human Research Participants. Am J Bioeth 2004 4 : 44 49
2. G. Henderson, A. Davis N. King. Vulnerability to Influence: A Two-Way Street. Am J Bioeth 2004 4 : 50 51.
3. K. Kipnis. 2001. Vulnerability in Research Subjects: A Bioethical Taxonomy. In Ethical and Policy Issues in Research Involving Human Participants. National Bioethics Advisory Commission (NBAC): Volume II - Commissioned Papers and Staff Analysis. Bethesda, MD: NBAC. Available at: http://onlineethics.org/ reseth/nbac/hkipnis.html [Accessed 1 June 2006].
4. Levine, op. cit. note 1; Henderson et al., op. cit. note 1.
5. th ed. Cape Town: MRC. Available at: http://www.sahealthinfo.org/ethics/ethicsbook1.pdf [Accessed 9 June 2006]; South Africa. Department of Health (DoH). 2000. Guidelines for Good Practice in the Conduct of Clinical trials in Human Participants in South Africa. Pretoria: DoH. Available at: http://www.doh.gov.za/docs/policy/trials/trials_contents.html [Accessed 9 June 2006]; United States Department of Health and Human Services (HHS). 2005. Code of Federal Regulations. Title 45. Part 46. Protection of Human Research Subjects. Washington, DC: HHS. Available at: http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.htm [Accessed 9 June 2006]; Medical Research Council (MRC). 1996. Guideline for Good Clinical Practice. Cape Town: MRC. Available at: http://www.mrc.ac.uk/pdf-ctg.pdf [Accessed 9 June 2006]: 'The guidelines are based on the thirteen principles laid down in the IHC Harmonized Tripartite Guideline for Good Clinical Practice agreed in May 1996.'
6. Council of International Organizations of Medical Sciences (CIOMS). 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: CIOMS in collaboration with the World Health Organization (WHO). Available at: http://www.cioms.ch/frame_guidelines_nov_2002.htm [Accessed 1 June 2006].
7. Kipnis, op. cit. note 2.
8. Henderson et al., op. cit. note 1.
9. R. Macklin. Bioethics, Vulnerability and Protection. Bioethics 2003 17 : 472 486.
10. S. Benatar. Avoiding Exploitation in Clinical Research. Camb Q Healthc Ethics 2000 9 : 562 565.
11. G. Churchyard et al. Mycobacterial Disease in South African Gold Miners in the Era of HIV Infection. Int J Tuberc Lung Dis 1999 3 : 791 798.
12. Consortium to Respond Effectively to the AIDS Epidemic (CREATE). For further information see CREATE website. Available at: http://www.tbhiv-create. org/index.htm [Accessed 8 June 2006].
13. Safety in Mines Research Advisory Committee (SIMRAC). For further information see the SIMRAC website. Available at: http://www.simrac.co.za/ [Accessed 1 June 2006].
14. rd ed. Cape Town: Reader's Digest Association South Africa.
15. Ibid.
16. S. Rose P.E. Pietri. Workers as Research Subjects: A Vulnerable Population. J Occup Environ Med 2002 44 : 801 805.
17. See t1 t1_legend_spanTable 1.
18. D. Cassaret, J.H. Karlawish J. Sugarman. Determining when Quality Improvement Initiatives should be Considered Research. JAMA 2000 283 : 2275 2280.
19. E.M. Ward, J.J. Hurrell M.J. Colligan. Ethical Issues in Occupational Health Research. Occupational Medicine: State of the Art Reviews 2002 17 : 637 655.
20. Medical Research Council, op. cit. note 4; United States Department of Health and Human Services, op. cit. note 4.
21. See t1 t1_legend_spanTable 1.
22. th ed. Oxford: Oxford University Press.
23. E. Emanuel. Introduction to Occupational Medical Ethics. Occup Med 2002 17 : 549 559
24. Beauchamp & Childress, op. cit. note 18.
25. The Nuremberg Code. 1949. Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law. Nuremberg, October 1946-April 1949. Washington, DC: US Government Printing Office: No.1; Vol.2: 181-182.
26. Ward et al., op. cit. note 18.
27. N.A. Christakis. The Ethical Design of an AIDS Vaccine Trial in Africa. Hastings Cent Rep 1988 18 (3 31 37.
28. See t1 t1_legend_spanTable 1.
29. Ibid.
30. A. Mastroianni J. Kahn. Swinging on the Pendulum: Shifting Views of Justice in Human Subjects Research. Hastings Cent Rep 2001 31 (3 21 28.
31. National Bioethics Advisory Commission (NBAC). 2001. Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries: Executive Summary. Bethesda, MD: NBAC. Available at: http://www.georgetown.edu/ research/nrcbl/nbac/clinical/execsum.html [Accessed 1 June 2006].
32. R. Lowenson, A. Laurell & C. Hogstedt. 1999. Participatory Approaches in Occupational Health Research. In Health and Work: Critical perspectives. N. Daykin & L. Doyal, eds. Basingstoke: Macmillan.
33. World Economic Forum. 2002. Agreement between Anglogold Limited and National Union of Mineworkers, MWU Solidarity, National Employees' Trade Union, South African Equity Workers Association, United Association of South Africa on HIV/AIDS in the Workplace. Geneva: World Economic Forum. Available at: http://www.weforum.org/pdf/Initiatives/GHI_HIV_Policy_Anglogold.pdf [Accessed 1 June 2006].
34. Ibid: section 8.
35. Lowenson et al., op. cit. note 31.
36. A. Laurell et al. Participatory Research on Workers' Health. Soc Sci Med 1992 34 : 603 613.
37. Ibid: 612.
38. Members of five CABs attended a debate and capacity building forum on 'Ethical-Legal Regulation of Research in South Africa: Implications for HIV Vaccine Trials', hosted by the HIV/AIDS Vaccine Working Group in Durban, South Africa in 2004. I was fortunate enough to facilitate a group session on informed consent, which included all the CAB members. I experienced first hand how articulately CAB members could express community concerns regarding issues such as unassisted adolescent consent. Researchers from the Desmond Tutu TB Centre at Stellenbosch University are currently involved in a very large public health research project-ZAMSTAR. They are working with CABs across 16 communities in South Africa and Zambia. A well-established CAB in Khayelitsha has worked with various groups of researchers from the University of Cape Town and Stellenbosch University (personal communication with investigators). Dr Nathaniel Khaole from the Department of Human Genetics, University of Cape Town has actively involved CABs in rural areas of the Western Cape, over a period of several years, in community based genetic studies into foetal alcohol syndrome.
39. R. Strauss et al. The Role of Community Advisory Boards: Involving Communities in the Informed Consent Process. Am J Public Health 2001 91 : 1938 1943.
40. J. Saveluscu. Two Deaths and Two Lessons: Is it Time to Review the Structure and Function of Research Ethics Committees? J Med Ethics 2002 28 : 3 4.
41. Laurell et al., op. cit. note 35, p. 612.
42. P. Strasheim. Ethics and Health - A Comprehensive Perspective, Part I. Occupational Health Southern Africa 2003 9 (5 4 7.